#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=Romina Mizrahi
1-1	0-6	Romina	person[1]	new[1]	coref	2-1[2_1]
1-2	7-14	Mizrahi	person[1]	new[1]	_	_

#Text=Romina Mizrahi is an Argentine-Canadian Associate Professor of Psychiatry at the University of Toronto and is a Head of the Focus on Youth Psychosis Prevention Clinic of the Centre for Addiction and Mental Health . [ 1 ]
2-1	15-21	Romina	person[2]	giv[2]	coref	2-4[4_2]
2-2	22-29	Mizrahi	person[2]	giv[2]	_	_
2-3	30-32	is	_	_	_	_
2-4	33-35	an	person[4]|person[5]	giv[4]|giv[5]	coref|coref	2-4[5_4]|4-1[19_5]
2-5	36-54	Argentine-Canadian	abstract|person[4]|person[5]	new|giv[4]|giv[5]	_	_
2-6	55-64	Associate	person[4]|person[5]	giv[4]|giv[5]	_	_
2-7	65-74	Professor	person[4]|person[5]	giv[4]|giv[5]	_	_
2-8	75-77	of	person[4]|person[5]	giv[4]|giv[5]	_	_
2-9	78-88	Psychiatry	person[4]|person[5]|abstract	giv[4]|giv[5]|new	coref	28-24[216_0]
2-10	89-91	at	person[4]|person[5]	giv[4]|giv[5]	_	_
2-11	92-95	the	person[4]|person[5]|organization[7]	giv[4]|giv[5]|new[7]	coref	4-23[29_7]
2-12	96-106	University	person[4]|person[5]|organization[7]	giv[4]|giv[5]|new[7]	_	_
2-13	107-109	of	person[4]|person[5]|organization[7]	giv[4]|giv[5]|new[7]	_	_
2-14	110-117	Toronto	person[4]|person[5]|organization[7]	giv[4]|giv[5]|new[7]	_	_
2-15	118-121	and	person[5]	giv[5]	_	_
2-16	122-124	is	person[5]	giv[5]	_	_
2-17	125-126	a	person[5]|person[8]	giv[5]|new[8]	_	_
2-18	127-131	Head	person[5]|person[8]	giv[5]|new[8]	_	_
2-19	132-134	of	person[5]|person[8]	giv[5]|new[8]	_	_
2-20	135-138	the	person[5]|person[8]|organization[9]	giv[5]|new[8]|new[9]	_	_
2-21	139-144	Focus	person[5]|person[8]|organization[9]	giv[5]|new[8]|new[9]	_	_
2-22	145-147	on	person[5]|person[8]|organization[9]	giv[5]|new[8]|new[9]	_	_
2-23	148-153	Youth	person[5]|person[8]|organization[9]|person|abstract[11]|abstract[12]|organization[13]	giv[5]|new[8]|new[9]|new|new[11]|new[12]|new[13]	coref	13-64[0_11]
2-24	154-163	Psychosis	person[5]|person[8]|organization[9]|abstract[11]|abstract[12]|organization[13]	giv[5]|new[8]|new[9]|new[11]|new[12]|new[13]	_	_
2-25	164-174	Prevention	person[5]|person[8]|organization[9]|abstract[12]|organization[13]	giv[5]|new[8]|new[9]|new[12]|new[13]	_	_
2-26	175-181	Clinic	person[5]|person[8]|organization[9]|organization[13]	giv[5]|new[8]|new[9]|new[13]	_	_
2-27	182-184	of	person[5]|person[8]|organization[9]|organization[13]	giv[5]|new[8]|new[9]|new[13]	_	_
2-28	185-188	the	person[5]|person[8]|organization[9]|organization[13]|organization[14]	giv[5]|new[8]|new[9]|new[13]|new[14]	_	_
2-29	189-195	Centre	person[5]|person[8]|organization[9]|organization[13]|organization[14]	giv[5]|new[8]|new[9]|new[13]|new[14]	_	_
2-30	196-199	for	person[5]|person[8]|organization[9]|organization[13]|organization[14]	giv[5]|new[8]|new[9]|new[13]|new[14]	_	_
2-31	200-209	Addiction	person[5]|person[8]|organization[9]|organization[13]|organization[14]|abstract	giv[5]|new[8]|new[9]|new[13]|new[14]|new	_	_
2-32	210-213	and	person[5]|person[8]|organization[9]|organization[13]|organization[14]	giv[5]|new[8]|new[9]|new[13]|new[14]	_	_
2-33	214-220	Mental	person[5]|person[8]|organization[9]|organization[13]|organization[14]|abstract[16]	giv[5]|new[8]|new[9]|new[13]|new[14]|new[16]	coref	8-17[0_16]
2-34	221-227	Health	person[5]|person[8]|organization[9]|organization[13]|organization[14]|abstract[16]	giv[5]|new[8]|new[9]|new[13]|new[14]|new[16]	_	_
2-35	228-229	.	_	_	_	_
2-36	230-231	[	_	_	_	_
2-37	232-233	1	abstract	new	_	_
2-38	234-235	]	_	_	_	_

#Text=Early and personal life
3-1	236-241	Early	abstract[18]	new[18]	_	_
3-2	242-245	and	abstract[18]	new[18]	_	_
3-3	246-254	personal	abstract[18]	new[18]	_	_
3-4	255-259	life	abstract[18]	new[18]	_	_

#Text=Romina Mizrahi had obtained her M.D. degree from the University of Buenos Aires in 1998 and in 2007 got her Ph.D. from the University of Toronto . [ 2 ]
4-1	260-266	Romina	person[19]	giv[19]	ana	4-5[0_19]
4-2	267-274	Mizrahi	person[19]	giv[19]	_	_
4-3	275-278	had	_	_	_	_
4-4	279-287	obtained	_	_	_	_
4-5	288-291	her	person|abstract[22]	giv|new[22]	ana	4-20
4-6	292-296	M.D.	time|abstract[22]	new|new[22]	_	_
4-7	297-303	degree	abstract[22]	new[22]	_	_
4-8	304-308	from	_	_	_	_
4-9	309-312	the	organization[23]	new[23]	_	_
4-10	313-323	University	organization[23]	new[23]	_	_
4-11	324-326	of	organization[23]	new[23]	_	_
4-12	327-333	Buenos	organization[23]|place[24]	new[23]|new[24]	_	_
4-13	334-339	Aires	organization[23]|place[24]	new[23]|new[24]	_	_
4-14	340-342	in	_	_	_	_
4-15	343-347	1998	time	new	_	_
4-16	348-351	and	_	_	_	_
4-17	352-354	in	_	_	_	_
4-18	355-359	2007	time	new	_	_
4-19	360-363	got	_	_	_	_
4-20	364-367	her	person|abstract[28]	giv|new[28]	ana	5-3
4-21	368-373	Ph.D.	abstract[28]	new[28]	_	_
4-22	374-378	from	_	_	_	_
4-23	379-382	the	organization[29]	giv[29]	_	_
4-24	383-393	University	organization[29]	giv[29]	_	_
4-25	394-396	of	organization[29]	giv[29]	_	_
4-26	397-404	Toronto	organization[29]	giv[29]	_	_
4-27	405-406	.	_	_	_	_
4-28	407-408	[	_	_	_	_
4-29	409-410	2	abstract	new	_	_
4-30	411-412	]	_	_	_	_

#Text=In 2008 she and her husband had moved to Canada and had two little girls which are three and nine months respectively . [ 3 ]
5-1	413-415	In	_	_	_	_
5-2	416-420	2008	time	new	_	_
5-3	421-424	she	person	giv	ana	5-5
5-4	425-428	and	_	_	_	_
5-5	429-432	her	person|person[34]	giv|new[34]	coref	11-5[79_0]
5-6	433-440	husband	person[34]	new[34]	_	_
5-7	441-444	had	_	_	_	_
5-8	445-450	moved	_	_	_	_
5-9	451-453	to	_	_	_	_
5-10	454-460	Canada	place	new	coref	9-16
5-11	461-464	and	_	_	_	_
5-12	465-468	had	_	_	_	_
5-13	469-472	two	person[36]	new[36]	_	_
5-14	473-479	little	person[36]	new[36]	_	_
5-15	480-485	girls	person[36]	new[36]	_	_
5-16	486-491	which	person[36]|time[37]	new[36]|new[37]	_	_
5-17	492-495	are	person[36]|time[37]	new[36]|new[37]	_	_
5-18	496-501	three	person[36]|time[37]	new[36]|new[37]	_	_
5-19	502-505	and	person[36]|time[37]	new[36]|new[37]	_	_
5-20	506-510	nine	person[36]|time[37]	new[36]|new[37]	_	_
5-21	511-517	months	person[36]|time[37]	new[36]|new[37]	_	_
5-22	518-530	respectively	person[36]|time[37]	new[36]|new[37]	_	_
5-23	531-532	.	_	_	_	_
5-24	533-534	[	_	_	_	_
5-25	535-536	3	abstract	new	_	_
5-26	537-538	]	_	_	_	_

#Text=Career
6-1	539-545	Career	abstract	new	_	_

#Text=Dr. Mizrahi is specializing in MRI , PET , phenomenology and pathophysiology and is an active seeker for the cure of schizophrenia .
7-1	546-549	Dr.	person[40]	new[40]	ana	8-1[0_40]
7-2	550-557	Mizrahi	person[40]	new[40]	_	_
7-3	558-560	is	_	_	_	_
7-4	561-573	specializing	_	_	_	_
7-5	574-576	in	_	_	_	_
7-6	577-580	MRI	abstract	new	_	_
7-7	581-582	,	_	_	_	_
7-8	583-586	PET	abstract	new	_	_
7-9	587-588	,	_	_	_	_
7-10	589-602	phenomenology	abstract	new	_	_
7-11	603-606	and	_	_	_	_
7-12	607-622	pathophysiology	abstract	new	_	_
7-13	623-626	and	_	_	_	_
7-14	627-629	is	_	_	_	_
7-15	630-632	an	person[45]	new[45]	_	_
7-16	633-639	active	person[45]	new[45]	_	_
7-17	640-646	seeker	person[45]	new[45]	_	_
7-18	647-650	for	person[45]	new[45]	_	_
7-19	651-654	the	person[45]|event[46]	new[45]|new[46]	_	_
7-20	655-659	cure	person[45]|event[46]	new[45]|new[46]	_	_
7-21	660-662	of	person[45]|event[46]	new[45]|new[46]	_	_
7-22	663-676	schizophrenia	person[45]|event[46]|abstract	new[45]|new[46]|new	coref	12-11[92_0]
7-23	677-678	.	_	_	_	_

#Text=She had received numerous funds from the National Institute of Mental Health , Canadian Institutes of Health Research and Ontario Mental Health Foundation with which she was able to develop a new radioligand F-18 .
8-1	679-682	She	person	giv	ana	8-26
8-2	683-686	had	_	_	_	_
8-3	687-695	received	_	_	_	_
8-4	696-704	numerous	abstract[49]	new[49]	_	_
8-5	705-710	funds	abstract[49]	new[49]	_	_
8-6	711-715	from	abstract[49]	new[49]	_	_
8-7	716-719	the	abstract[49]|organization[50]	new[49]|new[50]	_	_
8-8	720-728	National	abstract[49]|organization[50]	new[49]|new[50]	_	_
8-9	729-738	Institute	abstract[49]|organization[50]	new[49]|new[50]	_	_
8-10	739-741	of	abstract[49]|organization[50]	new[49]|new[50]	_	_
8-11	742-748	Mental	abstract[49]|organization[50]	new[49]|new[50]	_	_
8-12	749-755	Health	abstract[49]|organization[50]	new[49]|new[50]	_	_
8-13	756-757	,	abstract[49]	new[49]	_	_
8-14	758-766	Canadian	abstract[49]|organization[51]	new[49]|new[51]	_	_
8-15	767-777	Institutes	abstract[49]|organization[51]	new[49]|new[51]	_	_
8-16	778-780	of	abstract[49]|organization[51]	new[49]|new[51]	_	_
8-17	781-787	Health	abstract[49]|organization[51]|abstract|organization[53]	new[49]|new[51]|giv|new[53]	coref|coref	8-21[56_0]|9-22[0_53]
8-18	788-796	Research	abstract[49]|organization[51]|organization[53]	new[49]|new[51]|new[53]	_	_
8-19	797-800	and	abstract[49]	new[49]	_	_
8-20	801-808	Ontario	abstract[49]|place|organization[57]	new[49]|new|new[57]	coref|coref	9-18[71_57]|13-17[106_0]
8-21	809-815	Mental	abstract[49]|abstract|abstract[56]|organization[57]	new[49]|new|giv[56]|new[57]	coref	20-45[0_56]
8-22	816-822	Health	abstract[49]|abstract[56]|organization[57]	new[49]|giv[56]|new[57]	_	_
8-23	823-833	Foundation	abstract[49]|organization[57]	new[49]|new[57]	_	_
8-24	834-838	with	abstract[49]	new[49]	_	_
8-25	839-844	which	abstract[49]	new[49]	_	_
8-26	845-848	she	abstract[49]|person	new[49]|giv	ana	9-7
8-27	849-852	was	abstract[49]	new[49]	_	_
8-28	853-857	able	abstract[49]	new[49]	_	_
8-29	858-860	to	abstract[49]	new[49]	_	_
8-30	861-868	develop	abstract[49]	new[49]	_	_
8-31	869-870	a	abstract[49]|abstract[60]	new[49]|new[60]	_	_
8-32	871-874	new	abstract[49]|abstract[60]	new[49]|new[60]	_	_
8-33	875-886	radioligand	abstract[49]|place|abstract[60]	new[49]|new|new[60]	_	_
8-34	887-891	F-18	abstract[49]|abstract[60]	new[49]|new[60]	_	_
8-35	892-893	.	_	_	_	_

#Text=This advancement shed the light for her to continue research with the Alzheimer Society of Canada and the Brain & Behavior Research Foundation to test it on humans . [ 4 ] [ 5 ]
9-1	894-898	This	event[61]	new[61]	_	_
9-2	899-910	advancement	event[61]	new[61]	_	_
9-3	911-915	shed	_	_	_	_
9-4	916-919	the	abstract[62]	new[62]	_	_
9-5	920-925	light	abstract[62]	new[62]	_	_
9-6	926-929	for	_	_	_	_
9-7	930-933	her	person	giv	coref	16-7[144_0]
9-8	934-936	to	_	_	_	_
9-9	937-945	continue	_	_	_	_
9-10	946-954	research	abstract	new	ana	9-26
9-11	955-959	with	_	_	_	_
9-12	960-963	the	organization[66]	new[66]	_	_
9-13	964-973	Alzheimer	object|organization[66]	new|new[66]	_	_
9-14	974-981	Society	organization[66]	new[66]	_	_
9-15	982-984	of	organization[66]	new[66]	_	_
9-16	985-991	Canada	organization[66]|place	new[66]|giv	coref	11-20
9-17	992-995	and	_	_	_	_
9-18	996-999	the	organization[71]	giv[71]	_	_
9-19	1000-1005	Brain	object|organization[71]	new|giv[71]	coref	12-5
9-20	1006-1007	&	abstract[69]|organization[71]	new[69]|giv[71]	_	_
9-21	1008-1016	Behavior	abstract[69]|organization[71]	new[69]|giv[71]	_	_
9-22	1017-1025	Research	organization|organization[71]	giv|giv[71]	_	_
9-23	1026-1036	Foundation	organization[71]	giv[71]	_	_
9-24	1037-1039	to	_	_	_	_
9-25	1040-1044	test	_	_	_	_
9-26	1045-1047	it	abstract	giv	coref	13-5[102_0]
9-27	1048-1050	on	_	_	_	_
9-28	1051-1057	humans	animal	new	_	_
9-29	1058-1059	.	_	_	_	_
9-30	1060-1061	[	_	_	_	_
9-31	1062-1063	4	abstract	new	_	_
9-32	1064-1065	]	_	_	_	_
9-33	1066-1067	[	_	_	_	_
9-34	1068-1069	5	abstract	new	_	_
9-35	1070-1071	]	_	_	_	_

#Text=2015
10-1	1072-1076	2015	time	new	coref	11-2[77_0]

#Text=From 2015 to 2018 Romina Mizrahi had worked along with Tomas Paus and studied more than 1,600 boys from Canada , Britain , France , Germany and Ireland .
11-1	1077-1081	From	_	_	_	_
11-2	1082-1086	2015	time[77]	giv[77]	coref	13-2[0_77]
11-3	1087-1089	to	time[77]	giv[77]	_	_
11-4	1090-1094	2018	time[77]|time	giv[77]|new	coref	21-1
11-5	1095-1101	Romina	person[79]	giv[79]	coref	27-4[196_79]
11-6	1102-1109	Mizrahi	person[79]	giv[79]	_	_
11-7	1110-1113	had	_	_	_	_
11-8	1114-1120	worked	_	_	_	_
11-9	1121-1126	along	_	_	_	_
11-10	1127-1131	with	_	_	_	_
11-11	1132-1137	Tomas	person[80]	new[80]	ana	13-3[0_80]
11-12	1138-1142	Paus	person[80]	new[80]	_	_
11-13	1143-1146	and	_	_	_	_
11-14	1147-1154	studied	_	_	_	_
11-15	1155-1159	more	person[81]	new[81]	_	_
11-16	1160-1164	than	person[81]	new[81]	_	_
11-17	1165-1170	1,600	person[81]	new[81]	_	_
11-18	1171-1175	boys	person[81]	new[81]	_	_
11-19	1176-1180	from	person[81]	new[81]	_	_
11-20	1181-1187	Canada	person[81]|place	new[81]|giv	_	_
11-21	1188-1189	,	person[81]	new[81]	_	_
11-22	1190-1197	Britain	person[81]|place	new[81]|new	_	_
11-23	1198-1199	,	person[81]	new[81]	_	_
11-24	1200-1206	France	person[81]|place	new[81]|new	_	_
11-25	1207-1208	,	person[81]	new[81]	_	_
11-26	1209-1216	Germany	person[81]|place	new[81]|new	_	_
11-27	1217-1220	and	person[81]	new[81]	_	_
11-28	1221-1228	Ireland	person[81]|place	new[81]|new	_	_
11-29	1229-1230	.	_	_	_	_

#Text=The study looked into brain scans , cannabis history and genetic schizophrenia of the patients and was proven that there is cause-and-effect relationship between cannabis and brain changes . [ 6 ]
12-1	1231-1234	The	abstract[87]	new[87]	_	_
12-2	1235-1240	study	abstract[87]	new[87]	_	_
12-3	1241-1247	looked	_	_	_	_
12-4	1248-1252	into	_	_	_	_
12-5	1253-1258	brain	object|event[89]	giv|new[89]	coref	12-27
12-6	1259-1264	scans	event[89]	new[89]	_	_
12-7	1265-1266	,	_	_	_	_
12-8	1267-1275	cannabis	substance|abstract[91]	new|new[91]	coref	12-25
12-9	1276-1283	history	abstract[91]	new[91]	_	_
12-10	1284-1287	and	_	_	_	_
12-11	1288-1295	genetic	abstract[92]	giv[92]	_	_
12-12	1296-1309	schizophrenia	abstract[92]	giv[92]	_	_
12-13	1310-1312	of	abstract[92]	giv[92]	_	_
12-14	1313-1316	the	abstract[92]|person[93]	giv[92]|new[93]	coref	27-24[203_93]
12-15	1317-1325	patients	abstract[92]|person[93]	giv[92]|new[93]	_	_
12-16	1326-1329	and	_	_	_	_
12-17	1330-1333	was	_	_	_	_
12-18	1334-1340	proven	_	_	_	_
12-19	1341-1345	that	_	_	_	_
12-20	1346-1351	there	_	_	_	_
12-21	1352-1354	is	_	_	_	_
12-22	1355-1371	cause-and-effect	abstract[94]	new[94]	_	_
12-23	1372-1384	relationship	abstract[94]	new[94]	_	_
12-24	1385-1392	between	abstract[94]	new[94]	_	_
12-25	1393-1401	cannabis	abstract[94]|substance|substance[96]	new[94]|giv|new[96]	coref|coref	15-10[133_0]|25-7[190_96]
12-26	1402-1405	and	abstract[94]|substance[96]	new[94]|new[96]	_	_
12-27	1406-1411	brain	abstract[94]|substance[96]|object|event[98]	new[94]|new[96]|giv|new[98]	coref	13-71
12-28	1412-1419	changes	abstract[94]|substance[96]|event[98]	new[94]|new[96]|new[98]	_	_
12-29	1420-1421	.	_	_	_	_
12-30	1422-1423	[	_	_	_	_
12-31	1424-1425	6	abstract	new	_	_
12-32	1426-1427	]	_	_	_	_

#Text=In 2015 she led a research along with Sinthu Suntharalingam at the Children 's Hospital of Eastern Ontario on teenagers who used marijuana and proved that because it uses endocannabinoid system , [ 7 ] it should n't be used for people under the age of 25 [ 8 ] due to risk of memory loss , eruption of symptoms of schizophrenia and psychosis [ 9 ] and even permanent brain damage . [ 10 ]
13-1	1428-1430	In	_	_	_	_
13-2	1431-1435	2015	time	giv	_	_
13-3	1436-1439	she	person	giv	ana	15-4
13-4	1440-1443	led	_	_	_	_
13-5	1444-1445	a	abstract[102]	giv[102]	_	_
13-6	1446-1454	research	abstract[102]	giv[102]	_	_
13-7	1455-1460	along	abstract[102]|person[103]	giv[102]|new[103]	_	_
13-8	1461-1465	with	abstract[102]|person[103]	giv[102]|new[103]	_	_
13-9	1466-1472	Sinthu	abstract[102]|person[103]	giv[102]|new[103]	_	_
13-10	1473-1487	Suntharalingam	abstract[102]|person[103]	giv[102]|new[103]	_	_
13-11	1488-1490	at	abstract[102]|person[103]	giv[102]|new[103]	_	_
13-12	1491-1494	the	abstract[102]|person[103]|substance[105]	giv[102]|new[103]|new[105]	ana	13-28[0_105]
13-13	1495-1503	Children	abstract[102]|person[103]|person[104]|substance[105]	giv[102]|new[103]|new[104]|new[105]	_	_
13-14	1504-1506	's	abstract[102]|person[103]|person[104]|substance[105]	giv[102]|new[103]|new[104]|new[105]	_	_
13-15	1507-1515	Hospital	abstract[102]|person[103]|substance[105]	giv[102]|new[103]|new[105]	_	_
13-16	1516-1518	of	abstract[102]|person[103]|substance[105]	giv[102]|new[103]|new[105]	_	_
13-17	1519-1526	Eastern	abstract[102]|person[103]|substance[105]|place[106]	giv[102]|new[103]|new[105]|giv[106]	_	_
13-18	1527-1534	Ontario	abstract[102]|person[103]|substance[105]|place[106]	giv[102]|new[103]|new[105]|giv[106]	_	_
13-19	1535-1537	on	_	_	_	_
13-20	1538-1547	teenagers	person[107]	new[107]	_	_
13-21	1548-1551	who	person[107]	new[107]	_	_
13-22	1552-1556	used	person[107]	new[107]	_	_
13-23	1557-1566	marijuana	person[107]|substance	new[107]|new	_	_
13-24	1567-1570	and	_	_	_	_
13-25	1571-1577	proved	_	_	_	_
13-26	1578-1582	that	_	_	_	_
13-27	1583-1590	because	_	_	_	_
13-28	1591-1593	it	substance	giv	ana	13-36
13-29	1594-1598	uses	_	_	_	_
13-30	1599-1614	endocannabinoid	abstract[110]	new[110]	coref	27-21[0_110]
13-31	1615-1621	system	abstract[110]	new[110]	_	_
13-32	1622-1623	,	_	_	_	_
13-33	1624-1625	[	_	_	_	_
13-34	1626-1627	7	abstract	new	_	_
13-35	1628-1629	]	_	_	_	_
13-36	1630-1632	it	substance	giv	_	_
13-37	1633-1639	should	_	_	_	_
13-38	1640-1643	n't	_	_	_	_
13-39	1644-1646	be	_	_	_	_
13-40	1647-1651	used	_	_	_	_
13-41	1652-1655	for	_	_	_	_
13-42	1656-1662	people	person[113]	new[113]	_	_
13-43	1663-1668	under	person[113]	new[113]	_	_
13-44	1669-1672	the	person[113]|abstract[114]	new[113]|new[114]	_	_
13-45	1673-1676	age	person[113]|abstract[114]	new[113]|new[114]	_	_
13-46	1677-1679	of	person[113]|abstract[114]	new[113]|new[114]	_	_
13-47	1680-1682	25	person[113]|abstract[114]|abstract	new[113]|new[114]|new	_	_
13-48	1683-1684	[	_	_	_	_
13-49	1685-1686	8	abstract	new	_	_
13-50	1687-1688	]	_	_	_	_
13-51	1689-1692	due	_	_	_	_
13-52	1693-1695	to	_	_	_	_
13-53	1696-1700	risk	abstract[117]	new[117]	coref	30-11[224_117]
13-54	1701-1703	of	abstract[117]	new[117]	_	_
13-55	1704-1710	memory	abstract[117]|abstract|event[119]	new[117]|new|new[119]	_	_
13-56	1711-1715	loss	abstract[117]|event[119]	new[117]|new[119]	_	_
13-57	1716-1717	,	abstract[117]	new[117]	_	_
13-58	1718-1726	eruption	abstract[117]|event[120]	new[117]|new[120]	_	_
13-59	1727-1729	of	abstract[117]|event[120]	new[117]|new[120]	_	_
13-60	1730-1738	symptoms	abstract[117]|event[120]|abstract[121]	new[117]|new[120]|new[121]	_	_
13-61	1739-1741	of	abstract[117]|event[120]|abstract[121]	new[117]|new[120]|new[121]	_	_
13-62	1742-1755	schizophrenia	abstract[117]|event[120]|abstract[121]|abstract	new[117]|new[120]|new[121]|new	coref	19-10[156_0]
13-63	1756-1759	and	abstract[117]|event[120]|abstract[121]	new[117]|new[120]|new[121]	_	_
13-64	1760-1769	psychosis	abstract[117]|event[120]|abstract[121]|abstract	new[117]|new[120]|new[121]|giv	coref	15-23
13-65	1770-1771	[	_	_	_	_
13-66	1772-1773	9	abstract	new	_	_
13-67	1774-1775	]	_	_	_	_
13-68	1776-1779	and	_	_	_	_
13-69	1780-1784	even	event[126]	new[126]	_	_
13-70	1785-1794	permanent	event[126]	new[126]	_	_
13-71	1795-1800	brain	object|event[126]	giv|new[126]	_	_
13-72	1801-1807	damage	event[126]	new[126]	_	_
13-73	1808-1809	.	_	_	_	_
13-74	1810-1811	[	_	_	_	_
13-75	1812-1814	10	abstract	new	_	_
13-76	1815-1816	]	_	_	_	_

#Text=2016
14-1	1817-1821	2016	time	new	coref	15-3

#Text=In June 2016 she and Cory Gerritsen had studied cannabis ' ingredients ; cannabidiol and tetrahydrocannabinol and proved that the latter causes psychosis in adolescents . [ 11 ]
15-1	1822-1824	In	_	_	_	_
15-2	1825-1829	June	time[129]	new[129]	_	_
15-3	1830-1834	2016	time[129]|time	new[129]|giv	_	_
15-4	1835-1838	she	person	giv	_	_
15-5	1839-1842	and	_	_	_	_
15-6	1843-1847	Cory	person[132]	new[132]	_	_
15-7	1848-1857	Gerritsen	person[132]	new[132]	_	_
15-8	1858-1861	had	_	_	_	_
15-9	1862-1869	studied	_	_	_	_
15-10	1870-1878	cannabis	substance[133]|substance[134]	giv[133]|new[134]	appos|coref	15-14[0_134]|16-31[0_133]
15-11	1879-1880	'	substance[133]|substance[134]	giv[133]|new[134]	_	_
15-12	1881-1892	ingredients	substance[134]	new[134]	_	_
15-13	1893-1894	;	_	_	_	_
15-14	1895-1906	cannabidiol	substance|substance[136]	giv|giv[136]	appos|appos	15-14[136_0]|15-16[0_136]
15-15	1907-1910	and	substance[136]	giv[136]	_	_
15-16	1911-1931	tetrahydrocannabinol	substance[136]|substance	giv[136]|giv	_	_
15-17	1932-1935	and	_	_	_	_
15-18	1936-1942	proved	_	_	_	_
15-19	1943-1947	that	_	_	_	_
15-20	1948-1951	the	substance[138]	new[138]	_	_
15-21	1952-1958	latter	substance[138]	new[138]	_	_
15-22	1959-1965	causes	_	_	_	_
15-23	1966-1975	psychosis	abstract	giv	coref	19-27
15-24	1976-1978	in	_	_	_	_
15-25	1979-1990	adolescents	person	new	_	_
15-26	1991-1992	.	_	_	_	_
15-27	1993-1994	[	_	_	_	_
15-28	1995-1997	11	abstract	new	_	_
15-29	1998-1999	]	_	_	_	_

#Text=On November of the same year Dr. Mizrahi worked with Dr. Bill MacEwan on a case of a 21-year old who killed a 13-year old tween while being influenced by cannabis . [ 12 ]
16-1	2000-2002	On	_	_	_	_
16-2	2003-2011	November	time[142]	new[142]	_	_
16-3	2012-2014	of	time[142]	new[142]	_	_
16-4	2015-2018	the	time[142]|time[143]	new[142]|new[143]	coref	20-4[164_143]
16-5	2019-2023	same	time[142]|time[143]	new[142]|new[143]	_	_
16-6	2024-2028	year	time[142]|time[143]	new[142]|new[143]	_	_
16-7	2029-2032	Dr.	person[144]	giv[144]	coref	16-11[145_144]
16-8	2033-2040	Mizrahi	person[144]	giv[144]	_	_
16-9	2041-2047	worked	abstract	new	coref|none	28-16[213_0]|16-9[0_213]
16-10	2048-2052	with	_	_	_	_
16-11	2053-2056	Dr.	person[145]	giv[145]	coref	19-1[0_145]
16-12	2057-2061	Bill	person[145]	giv[145]	_	_
16-13	2062-2069	MacEwan	person[145]	giv[145]	_	_
16-14	2070-2072	on	_	_	_	_
16-15	2073-2074	a	abstract[146]	new[146]	_	_
16-16	2075-2079	case	abstract[146]	new[146]	_	_
16-17	2080-2082	of	abstract[146]	new[146]	_	_
16-18	2083-2084	a	abstract[146]	new[146]	_	_
16-19	2085-2092	21-year	abstract[146]	new[146]	_	_
16-20	2093-2096	old	abstract[146]	new[146]	_	_
16-21	2097-2100	who	abstract[146]	new[146]	_	_
16-22	2101-2107	killed	abstract[146]	new[146]	_	_
16-23	2108-2109	a	abstract[146]|person[147]	new[146]|new[147]	_	_
16-24	2110-2117	13-year	abstract[146]|person[147]	new[146]|new[147]	_	_
16-25	2118-2121	old	abstract[146]|person[147]	new[146]|new[147]	_	_
16-26	2122-2127	tween	abstract[146]|person[147]	new[146]|new[147]	_	_
16-27	2128-2133	while	_	_	_	_
16-28	2134-2139	being	_	_	_	_
16-29	2140-2150	influenced	_	_	_	_
16-30	2151-2153	by	_	_	_	_
16-31	2154-2162	cannabis	substance	giv	coref	20-32
16-32	2163-2164	.	_	_	_	_
16-33	2165-2166	[	_	_	_	_
16-34	2167-2169	12	abstract	new	_	_
16-35	2170-2171	]	_	_	_	_

#Text=2017
17-1	2172-2176	2017	time	new	coref	18-3

#Text=In January 2017
18-1	2177-2179	In	_	_	_	_
18-2	2180-2187	January	time[151]	new[151]	_	_
18-3	2188-2192	2017	time[151]|time	new[151]|giv	_	_

#Text=Mizrahi had studied Canadian immigrants for the symptoms of schizophrenia which was caused by dopamine [ 13 ] and established a possible link between migration and psychosis . [ 14 ]
19-1	2193-2200	Mizrahi	person	giv	ana	20-7
19-2	2201-2204	had	_	_	_	_
19-3	2205-2212	studied	_	_	_	_
19-4	2213-2221	Canadian	person[154]	new[154]	_	_
19-5	2222-2232	immigrants	person[154]	new[154]	_	_
19-6	2233-2236	for	_	_	_	_
19-7	2237-2240	the	abstract[155]	new[155]	coref	25-18[192_155]
19-8	2241-2249	symptoms	abstract[155]	new[155]	_	_
19-9	2250-2252	of	abstract[155]	new[155]	_	_
19-10	2253-2266	schizophrenia	abstract[155]|abstract[156]	new[155]|giv[156]	_	_
19-11	2267-2272	which	abstract[155]|abstract[156]	new[155]|giv[156]	_	_
19-12	2273-2276	was	abstract[155]|abstract[156]	new[155]|giv[156]	_	_
19-13	2277-2283	caused	abstract[155]|abstract[156]	new[155]|giv[156]	_	_
19-14	2284-2286	by	abstract[155]|abstract[156]	new[155]|giv[156]	_	_
19-15	2287-2295	dopamine	abstract[155]|abstract[156]|substance	new[155]|giv[156]|new	_	_
19-16	2296-2297	[	_	_	_	_
19-17	2298-2300	13	abstract	new	_	_
19-18	2301-2302	]	_	_	_	_
19-19	2303-2306	and	_	_	_	_
19-20	2307-2318	established	_	_	_	_
19-21	2319-2320	a	abstract[159]	new[159]	coref	25-3[188_159]
19-22	2321-2329	possible	abstract[159]	new[159]	_	_
19-23	2330-2334	link	abstract[159]	new[159]	_	_
19-24	2335-2342	between	abstract[159]	new[159]	_	_
19-25	2343-2352	migration	abstract[159]|abstract	new[159]|new	_	_
19-26	2353-2356	and	abstract[159]	new[159]	_	_
19-27	2357-2366	psychosis	abstract[159]|abstract	new[159]|giv	coref	30-9
19-28	2367-2368	.	_	_	_	_
19-29	2369-2370	[	_	_	_	_
19-30	2371-2373	14	abstract	new	_	_
19-31	2374-2375	]	_	_	_	_

#Text=In May of the same year she had partnered with Diane Kelsall who was a chief editor of the Canadian Medical Association Journal to push for a stricter guidelines in the Cannabis Act , which were approved later on by the Canadian Minister of Health Jane Philpott . [ 15 ]
20-1	2376-2378	In	_	_	_	_
20-2	2379-2382	May	time[163]	new[163]	coref	22-2[179_163]
20-3	2383-2385	of	time[163]	new[163]	_	_
20-4	2386-2389	the	time[163]|time[164]	new[163]|giv[164]	_	_
20-5	2390-2394	same	time[163]|time[164]	new[163]|giv[164]	_	_
20-6	2395-2399	year	time[163]|time[164]	new[163]|giv[164]	_	_
20-7	2400-2403	she	person	giv	coref	28-4[209_0]
20-8	2404-2407	had	_	_	_	_
20-9	2408-2417	partnered	_	_	_	_
20-10	2418-2422	with	_	_	_	_
20-11	2423-2428	Diane	person[166]	new[166]	_	_
20-12	2429-2436	Kelsall	person[166]	new[166]	_	_
20-13	2437-2440	who	person[166]|person[167]	new[166]|new[167]	_	_
20-14	2441-2444	was	person[166]|person[167]	new[166]|new[167]	_	_
20-15	2445-2446	a	person[166]|person[167]	new[166]|new[167]	_	_
20-16	2447-2452	chief	person[166]|person[167]	new[166]|new[167]	_	_
20-17	2453-2459	editor	person[166]|person[167]	new[166]|new[167]	_	_
20-18	2460-2462	of	person[166]|person[167]	new[166]|new[167]	_	_
20-19	2463-2466	the	person[166]|person[167]|organization[170]	new[166]|new[167]|new[170]	coref	28-21[215_170]
20-20	2467-2475	Canadian	person[166]|person[167]|organization[169]|organization[170]	new[166]|new[167]|new[169]|new[170]	_	_
20-21	2476-2483	Medical	person[166]|person[167]|substance|organization[169]|organization[170]	new[166]|new[167]|new|new[169]|new[170]	_	_
20-22	2484-2495	Association	person[166]|person[167]|organization[169]|organization[170]	new[166]|new[167]|new[169]|new[170]	_	_
20-23	2496-2503	Journal	person[166]|person[167]|organization[170]	new[166]|new[167]|new[170]	_	_
20-24	2504-2506	to	_	_	_	_
20-25	2507-2511	push	_	_	_	_
20-26	2512-2515	for	_	_	_	_
20-27	2516-2517	a	abstract[171]	new[171]	_	_
20-28	2518-2526	stricter	abstract[171]	new[171]	_	_
20-29	2527-2537	guidelines	abstract[171]	new[171]	_	_
20-30	2538-2540	in	abstract[171]	new[171]	_	_
20-31	2541-2544	the	abstract[171]|abstract[173]	new[171]|new[173]	_	_
20-32	2545-2553	Cannabis	abstract[171]|substance|abstract[173]	new[171]|giv|new[173]	coref	23-1
20-33	2554-2557	Act	abstract[171]|abstract[173]	new[171]|new[173]	_	_
20-34	2558-2559	,	abstract[171]	new[171]	_	_
20-35	2560-2565	which	abstract[171]	new[171]	_	_
20-36	2566-2570	were	abstract[171]	new[171]	_	_
20-37	2571-2579	approved	abstract[171]	new[171]	_	_
20-38	2580-2585	later	abstract[171]	new[171]	_	_
20-39	2586-2588	on	abstract[171]	new[171]	_	_
20-40	2589-2591	by	abstract[171]	new[171]	_	_
20-41	2592-2595	the	abstract[171]|organization[174]	new[171]|new[174]	_	_
20-42	2596-2604	Canadian	abstract[171]|organization[174]	new[171]|new[174]	_	_
20-43	2605-2613	Minister	abstract[171]|organization[174]	new[171]|new[174]	_	_
20-44	2614-2616	of	abstract[171]|organization[174]	new[171]|new[174]	_	_
20-45	2617-2623	Health	abstract[171]|organization[174]|abstract	new[171]|new[174]|giv	_	_
20-46	2624-2628	Jane	person[176]	new[176]	ana	22-11[0_176]
20-47	2629-2637	Philpott	person[176]	new[176]	_	_
20-48	2638-2639	.	_	_	_	_
20-49	2640-2641	[	_	_	_	_
20-50	2642-2644	15	abstract	new	_	_
20-51	2645-2646	]	_	_	_	_

#Text=2018
21-1	2647-2651	2018	time	giv	coref	22-3

#Text=In May 2018 , in an interview with Leafly , she told the site that
22-1	2652-2654	In	_	_	_	_
22-2	2655-2658	May	time[179]	giv[179]	_	_
22-3	2659-2663	2018	time[179]|time	giv[179]|giv	coref	27-3
22-4	2664-2665	,	_	_	_	_
22-5	2666-2668	in	_	_	_	_
22-6	2669-2671	an	event[181]	new[181]	_	_
22-7	2672-2681	interview	event[181]	new[181]	_	_
22-8	2682-2686	with	event[181]	new[181]	_	_
22-9	2687-2693	Leafly	event[181]|animal	new[181]|new	_	_
22-10	2694-2695	,	_	_	_	_
22-11	2696-2699	she	person	giv	_	_
22-12	2700-2704	told	_	_	_	_
22-13	2705-2708	the	organization[184]	new[184]	_	_
22-14	2709-2713	site	organization[184]	new[184]	_	_
22-15	2714-2718	that	_	_	_	_

#Text=Cannabis could be a trigger of an underlying condition .
23-1	2719-2727	Cannabis	substance	giv	coref	23-4[186_0]
23-2	2728-2733	could	_	_	_	_
23-3	2734-2736	be	_	_	_	_
23-4	2737-2738	a	substance[186]	giv[186]	coref	25-7[0_186]
23-5	2739-2746	trigger	substance[186]	giv[186]	_	_
23-6	2747-2749	of	substance[186]	giv[186]	_	_
23-7	2750-2752	an	substance[186]|abstract[187]	giv[186]|new[187]	_	_
23-8	2753-2763	underlying	substance[186]|abstract[187]	giv[186]|new[187]	_	_
23-9	2764-2773	condition	substance[186]|abstract[187]	giv[186]|new[187]	_	_
23-10	2774-2775	.	_	_	_	_

#Text=and that
24-1	2776-2779	and	_	_	_	_
24-2	2780-2784	that	_	_	_	_

#Text=There is a proven link between cannabis and psychotic experience , [ but ] who will experience those symptoms or when [ remains unclear ] .
25-1	2785-2790	There	_	_	_	_
25-2	2791-2793	is	_	_	_	_
25-3	2794-2795	a	abstract[188]	giv[188]	_	_
25-4	2796-2802	proven	abstract[188]	giv[188]	_	_
25-5	2803-2807	link	abstract[188]	giv[188]	_	_
25-6	2808-2815	between	abstract[188]	giv[188]	_	_
25-7	2816-2824	cannabis	abstract[188]|substance|substance[190]	giv[188]|giv|giv[190]	coref	28-19
25-8	2825-2828	and	abstract[188]|substance[190]	giv[188]|giv[190]	_	_
25-9	2829-2838	psychotic	abstract[188]|substance[190]|abstract[191]	giv[188]|giv[190]|new[191]	_	_
25-10	2839-2849	experience	abstract[188]|substance[190]|abstract[191]	giv[188]|giv[190]|new[191]	_	_
25-11	2850-2851	,	abstract[188]	giv[188]	_	_
25-12	2852-2853	[	abstract[188]	giv[188]	_	_
25-13	2854-2857	but	abstract[188]	giv[188]	_	_
25-14	2858-2859	]	abstract[188]	giv[188]	_	_
25-15	2860-2863	who	abstract[188]	giv[188]	_	_
25-16	2864-2868	will	abstract[188]	giv[188]	_	_
25-17	2869-2879	experience	abstract[188]	giv[188]	_	_
25-18	2880-2885	those	abstract[188]|abstract[192]	giv[188]|giv[192]	_	_
25-19	2886-2894	symptoms	abstract[188]|abstract[192]	giv[188]|giv[192]	_	_
25-20	2895-2897	or	_	_	_	_
25-21	2898-2902	when	_	_	_	_
25-22	2903-2904	[	_	_	_	_
25-23	2905-2912	remains	_	_	_	_
25-24	2913-2920	unclear	_	_	_	_
25-25	2921-2922	]	_	_	_	_
25-26	2923-2924	.	_	_	_	_

#Text=[ 16 ]
26-1	2925-2926	[	_	_	_	_
26-2	2927-2929	16	abstract	new	_	_
26-3	2930-2931	]	_	_	_	_

#Text=In July 2018 Romina Mizrahi had suggested that cortisol , the main stress hormone , is responsible for stress regulatory system failures with schizophrenic patients by studying their striatum . [ 17 ]
27-1	2932-2934	In	_	_	_	_
27-2	2935-2939	July	time[194]	new[194]	_	_
27-3	2940-2944	2018	time[194]|time	new[194]|giv	coref	28-3
27-4	2945-2951	Romina	person[196]	giv[196]	coref	30-14[225_196]
27-5	2952-2959	Mizrahi	person[196]	giv[196]	_	_
27-6	2960-2963	had	_	_	_	_
27-7	2964-2973	suggested	_	_	_	_
27-8	2974-2978	that	_	_	_	_
27-9	2979-2987	cortisol	substance	new	appos	27-11[199_0]
27-10	2988-2989	,	_	_	_	_
27-11	2990-2993	the	substance[199]	giv[199]	_	_
27-12	2994-2998	main	substance[199]	giv[199]	_	_
27-13	2999-3005	stress	abstract|substance[199]	new|giv[199]	coref	27-19
27-14	3006-3013	hormone	substance[199]	giv[199]	_	_
27-15	3014-3015	,	_	_	_	_
27-16	3016-3018	is	_	_	_	_
27-17	3019-3030	responsible	_	_	_	_
27-18	3031-3034	for	_	_	_	_
27-19	3035-3041	stress	abstract|event[202]	giv|new[202]	_	_
27-20	3042-3052	regulatory	event[202]	new[202]	_	_
27-21	3053-3059	system	abstract|event[202]	giv|new[202]	_	_
27-22	3060-3068	failures	event[202]	new[202]	_	_
27-23	3069-3073	with	event[202]	new[202]	_	_
27-24	3074-3087	schizophrenic	event[202]|person[203]	new[202]|giv[203]	ana	27-28[0_203]
27-25	3088-3096	patients	event[202]|person[203]	new[202]|giv[203]	_	_
27-26	3097-3099	by	_	_	_	_
27-27	3100-3108	studying	_	_	_	_
27-28	3109-3114	their	person|abstract[205]	giv|new[205]	ana	28-16
27-29	3115-3123	striatum	abstract[205]	new[205]	_	_
27-30	3124-3125	.	_	_	_	_
27-31	3126-3127	[	_	_	_	_
27-32	3128-3130	17	abstract	new	_	_
27-33	3131-3132	]	_	_	_	_

#Text=In October 2018 Dr. Mizrahi partnered with Randi Schuster of Massachusetts General Hospital and published their work on cannabis in The Journal of Clinical Psychiatry . [ 18 ]
28-1	3133-3135	In	_	_	_	_
28-2	3136-3143	October	time[207]	new[207]	_	_
28-3	3144-3148	2018	time[207]|time	new[207]|giv	coref	30-1
28-4	3149-3152	Dr.	person[209]	giv[209]	_	_
28-5	3153-3160	Mizrahi	person[209]	giv[209]	_	_
28-6	3161-3170	partnered	_	_	_	_
28-7	3171-3175	with	_	_	_	_
28-8	3176-3181	Randi	person[210]	new[210]	_	_
28-9	3182-3190	Schuster	person[210]	new[210]	_	_
28-10	3191-3193	of	person[210]	new[210]	_	_
28-11	3194-3207	Massachusetts	person[210]|organization[211]	new[210]|new[211]	_	_
28-12	3208-3215	General	person[210]|organization[211]	new[210]|new[211]	_	_
28-13	3216-3224	Hospital	person[210]|organization[211]	new[210]|new[211]	_	_
28-14	3225-3228	and	_	_	_	_
28-15	3229-3238	published	_	_	_	_
28-16	3239-3244	their	person|abstract[213]	giv|new[213]	_	_
28-17	3245-3249	work	abstract[213]	new[213]	_	_
28-18	3250-3252	on	abstract[213]	new[213]	_	_
28-19	3253-3261	cannabis	abstract[213]|substance	new[213]|giv	_	_
28-20	3262-3264	in	_	_	_	_
28-21	3265-3268	The	organization[215]	giv[215]	_	_
28-22	3269-3276	Journal	organization[215]	giv[215]	_	_
28-23	3277-3279	of	organization[215]	giv[215]	_	_
28-24	3280-3288	Clinical	organization[215]|abstract[216]	giv[215]|giv[216]	_	_
28-25	3289-3299	Psychiatry	organization[215]|abstract[216]	giv[215]|giv[216]	_	_
28-26	3300-3301	.	_	_	_	_
28-27	3302-3303	[	_	_	_	_
28-28	3304-3306	18	abstract	new	_	_
28-29	3307-3308	]	_	_	_	_

#Text=Works
29-1	3309-3314	Works	_	_	_	_

#Text=2018 - Molecular imaging studies in youth with psychosis and psychosis risk with Dr Romina Mizrahi [ 19 ]
30-1	3315-3319	2018	time|abstract[220]	giv|new[220]	_	_
30-2	3320-3321	-	abstract[220]	new[220]	_	_
30-3	3322-3331	Molecular	abstract[219]|abstract[220]	new[219]|new[220]	_	_
30-4	3332-3339	imaging	abstract[219]|abstract[220]	new[219]|new[220]	_	_
30-5	3340-3347	studies	abstract[220]	new[220]	_	_
30-6	3348-3350	in	abstract[220]	new[220]	_	_
30-7	3351-3356	youth	abstract[220]|person[221]	new[220]|new[221]	_	_
30-8	3357-3361	with	abstract[220]|person[221]	new[220]|new[221]	_	_
30-9	3362-3371	psychosis	abstract[220]|person[221]|abstract	new[220]|new[221]|giv	coref	30-11
30-10	3372-3375	and	abstract[220]|person[221]	new[220]|new[221]	_	_
30-11	3376-3385	psychosis	abstract[220]|person[221]|abstract|abstract[224]	new[220]|new[221]|giv|giv[224]	_	_
30-12	3386-3390	risk	abstract[220]|person[221]|abstract[224]	new[220]|new[221]|giv[224]	_	_
30-13	3391-3395	with	abstract[220]	new[220]	_	_
30-14	3396-3398	Dr	abstract[220]|person[225]	new[220]|giv[225]	_	_
30-15	3399-3405	Romina	abstract[220]|person[225]	new[220]|giv[225]	_	_
30-16	3406-3413	Mizrahi	abstract[220]|person[225]	new[220]|giv[225]	_	_
30-17	3414-3415	[	_	_	_	_
30-18	3416-3418	19	abstract	new	_	_
30-19	3419-3420	]	_	_	_	_
